Liu Jiankai Innovation Studio of Minhai Biotechnology has been awarded the “National Model Worker Team” title.

Release date:

2018-05-11

Author:

Contributed by the General Office

Source:


Abstract

On April 27, the “Striving in the New Era—Labor Writes a New Chapter” celebration marking International Labor Day and the advanced‑worker commendation conference kicked off in Daxing District, Beijing. The Liu Jiankai Innovation Studio of Beijing Minhai Biotechnology Co., Ltd. was honored with the title of “National Model Worker Team.” The “National Model Worker Team” is an honorary designation established and issued by the All-China Federation of Trade Unions, with activities centered on achieving first‑class work, first‑class service, first‑class performance, and a first‑class team.

  On April 27, the “Striving in the New Era—Labor Writes a New Chapter” celebration marking International Labor Day and the advanced‑worker commendation conference kicked off in Daxing District, Beijing. The Liu Jiankai Innovation Studio of Beijing Minhai Biotechnology Co., Ltd. was honored with the title of “National Model Worker Team.” The “National Model Worker Team” is an honorary designation established and issued by the All-China Federation of Trade Unions, with activities centered on achieving excellence in work, service, performance, and team building.

  The Liu Jiankai Innovation Studio was established in 2012, undertaking the development of novel vaccines and the upgrading of conventional vaccines for Minhai Biotechnology. It has earned recognition within the industry as an “innovation benchmark.” Since its inception, the studio has leveraged its concentration of high‑tech talent to vigorously organize diverse talent‑development initiatives; it has also tapped into the collective expertise of its scientific and technical personnel, focusing on pressing and challenging issues in vaccine R&D, collaboratively exploring innovative approaches, and driving the company’s innovative growth. To date, the studio has undertaken more than 30 national and provincial‑ministerial research projects, including seven major special programs for new drug development, and has participated in the creation of over 20 innovative vaccine candidates that boast independent intellectual property rights and cutting‑edge technological capabilities both domestically and internationally.

  Staying true to our original aspiration and forging ahead with determination, the Liu Jiankai Innovation Studio will continue to uphold the spirit of innovation, focus on tackling the most challenging issues in vaccine research, develop more vaccine products with independent intellectual property rights, build a robust national health‑protection barrier, and safeguard human health!

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09